Astera Labs, Inc. $ALAB Shares Sold by Left Brain Wealth Management LLC

Left Brain Wealth Management LLC lessened its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 58.6% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,848 shares of the company’s stock after selling 2,620 shares during the period. Left Brain Wealth Management LLC’s holdings in Astera Labs were worth $658,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Amazon Com Inc. acquired a new position in Astera Labs during the 2nd quarter worth about $134,172,000. Edgestream Partners L.P. bought a new stake in Astera Labs during the 1st quarter worth about $1,891,000. Lido Advisors LLC increased its position in Astera Labs by 123.4% in the 1st quarter. Lido Advisors LLC now owns 27,477 shares of the company’s stock valued at $3,012,000 after acquiring an additional 15,180 shares in the last quarter. Strs Ohio increased its position in Astera Labs by 996.3% in the 1st quarter. Strs Ohio now owns 33,086 shares of the company’s stock valued at $3,626,000 after acquiring an additional 30,068 shares in the last quarter. Finally, Silvant Capital Management LLC acquired a new stake in Astera Labs in the 2nd quarter valued at about $11,277,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research analyst reports. Royal Bank Of Canada boosted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Susquehanna raised their price target on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Morgan Stanley boosted their price objective on shares of Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Finally, Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, October 9th. Eleven analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $340.79.

Astera Labs Trading Down 10.9%

Shares of NASDAQ:ALAB opened at $258.70 on Friday. The stock has a market capitalization of $44.88 billion, a P/E ratio of 187.37 and a beta of 3.68. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The business has a 50-day moving average price of $308.12 and a two-hundred day moving average price of $254.98.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the previous year, the business earned $0.44 EPS. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 2.71 EPS for the current year.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock valued at $127,306,034 over the last 90 days. Insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.